The Autism Impact Measure (AIM): Examination of Sensitivity to Change
- 1 October 2020
- journal article
- research article
- Published by Wiley in Autism Research
- Vol. 13 (11) , 1867-1879
Abstract
The Autism Impact Measure (AIM) was designed specifically for treatment‐outcome assessment in children with ASD, focusing on treatment‐relevant aspects of symptom presentation and efficient detection of short‐term improvement. The AIM demonstrated strong reliability and validity in initial psychometric studies. The current study evaluated the AIM's sensitivity to change across well‐established treatments. The sample included 471 children with ASD (ages 2–14) participating in one of six treatments. The AIM was administered at baseline and 6‐week intervals and a battery of domain‐specific concurrent measures was also administered. A longitudinal repeated measures design examined the degree to which: (a) AIM domain scores changed over time in response to treatment and (b) change in AIM domains was associated with change in measures of similar constructs. Results across growth curve models indicated that AIM domains are sensitive to change in symptoms across treatment. Across all models, symptoms decreased over time, with some deceleration in rate of improvement. For all AIM domains except Repetitive Behavior, symptoms improved as a function of treatment group. Correlations of change between AIM and other measures varied across domains (from 0.01–0.43 across measures). This was the first large‐scale study to systematically evaluate sensitivity to change in a measure of core ASD symptoms. The results provide support for the AIM's ability to detect short‐term improvement across symptom domains and indicate that AIM domains are sensitive to change overall and as a function of different treatment conditions. The brief repeated assessment window also highlights the AIM's utility for detecting improvements across short‐term treatments. Autism Res 2020, 13: 1867‐1879. © 2020 International Society for Autism Research and Wiley Periodicals LLCLay Summary: Good measures are important for assessing outcomes in children with autism. However, there are few tools for tracking short‐term changes in autism symptoms. This study tested a new measure, the Autism Impact Measure (AIM), in a large group of children with autism. The results showed that the AIM appears to be a valid and accurate tool for measuring autism symptoms. The AIM may be a helpful tool for researchers and clinicians interested in tracking short‐term improvements in autism symptoms.Keywords
Funding Information
- National Institutes of Health (R01MH097726)
This publication has 42 references indexed in Scilit:
- Accelerating research on treatment and services for transition age youth and adults on the autism spectrumAutism, 2018
- Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum DisorderJournal of Child and Adolescent Psychopharmacology, 2017
- The Social ABCs caregiver‐mediated intervention for toddlers with autism spectrum disorder: Feasibility, acceptability, and evidence of promise from a multisite studyAutism Research, 2015
- Measuring social communication behaviors as a treatment endpoint in individuals with autism spectrum disorderAutism, 2014
- Costs of Autism Spectrum Disorders in the United Kingdom and the United StatesJAMA Pediatrics, 2014
- Diagnostic and Statistical Manual of Mental Disorders2013
- Measurement Tools and Target Symptoms/Skills Used to Assess Treatment Response for Individuals with Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2013
- What Happens Next? Follow-Up From the Children’s Toddler School ProgramJournal of Positive Behavior Interventions, 2010
- Varieties of Repetitive Behavior in Autism: Comparisons to Mental RetardationJournal of Autism and Developmental Disorders, 2000
- Aberrant Behavior Checklist1985